[
  {
    "date": "2023-12-30",
    "symbol": "IPHYF",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39084",
    "entityregistrantname": "Innate Pharma SA",
    "entityincorporationstatecountrycode": "I0",
    "entityaddressaddressline1": "117, Avenue de Luminy",
    "entityaddresspostalzipcode": 13009,
    "entityaddresscityortown": "Marseille",
    "entityaddresscountry": "FR",
    "contactpersonnelname": "Hervé Brailly",
    "cityareacode": 33,
    "localphonenumber": "4 30 30 30 30",
    "security12btitle": "American Depositary Shares, each representing one ordinary share, nominal value €0.05 per share",
    "tradingsymbol": "IPHA",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 80453282,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1598599,
    "amendmentflag": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "auditorfirmid": 1756,
    "auditorname": "Deloitte & Associés",
    "auditorlocation": "Paris La Défense, France",
    "intangibleassetsotherthangoodwill": 416000,
    "propertyplantandequipmentincludingrightofuseassets": 6322000,
    "noncurrentfinancialassets": 9796000,
    "othernoncurrentnonfinancialassets": 87000,
    "noncurrentreceivables": 10554000,
    "deferredtaxassets": 9006000,
    "noncurrentassets": 36181000,
    "cashandcashequivalents": 70605000,
    "currentfinancialassets": 21851000,
    "tradeandothercurrentreceivables": 55557000,
    "currentassets": 148012000,
    "assets": 184193000,
    "issuedcapital": 4044000,
    "sharepremium": 384255000,
    "reservesandretainedearnings": -329323000,
    "otherreserves": 495000,
    "netincomelosses": -7570000,
    "equity": 51901000,
    "collaborationliabilitiesnoncurrent": 45030000,
    "noncurrentfinancialliabilities": 30957000,
    "noncurrentprovisionsforemployeebenefits": 2441000,
    "noncurrentdeferredincomeincludingnoncurrentcontractliabilities": 4618000,
    "noncurrentprovisions": 603000,
    "deferredtaxliabilities": 9006000,
    "noncurrentliabilities": 92656000,
    "tradeandothercurrentpayables": 17018000,
    "collaborationliabilitiescurrent": 7647000,
    "currentfinancialliabilities": 8936000,
    "currentdeferredincomeincludingcurrentcontractliabilities": 5865000,
    "currentprovisions": 171000,
    "currentliabilities": 39637000,
    "equityandliabilities": 184193000,
    "revenuefromcontractswithcustomers": 51901000,
    "governmentfinancingforresearchexpenditures": 9729000,
    "otherincome": 11000,
    "revenue": 61641000,
    "researchanddevelopmentexpense": 56022000,
    "sellinggeneralandadministrativeexpense": 18288000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 41000000,
    "operatingexpense": 74310000,
    "profitlossfromoperatingactivities": -12669000,
    "financeincome": 6934000,
    "financecosts": 1835000,
    "financeincomecost": 5099000,
    "profitlossbeforetax": -7570000,
    "profitlossfromcontinuingoperations": -7570000,
    "profitloss": -7570000,
    "basicearningslosspershare": -0.09,
    "dilutedearningslosspershare": -0.09,
    "basicearningslosspersharefromcontinuingoperations": -0.09,
    "dilutedearningslosspersharefromcontinuingoperations": -0.09,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 276000,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": 394000,
    "othercomprehensiveincome": 670000,
    "comprehensiveincome": -6900000,
    "adjustmentsfordepreciationandamortisationexpense": 5091000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 285000,
    "adjustmentsforprovisions": -966000,
    "adjustmentsforsharebasedpayments": 4256000,
    "adjustmentsforfairvaluegainslosses": -1592000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 544000,
    "adjustmentsforfinanceincome": 991000,
    "adjustmentsforgainlossondisposalspropertyplantandequipment": -470000,
    "otheradjustmentstoreconcileprofitloss": 6000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -467000,
    "increasedecreaseinworkingcapital": 32091000,
    "cashflowsfromusedinoperatingactivities": -32558000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 2000000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 351000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 150000,
    "proceedsfromotherlongtermassetsclassifiedasinvestingactivities": 66000,
    "purchaseofotherlongtermassetsclassifiedasinvestingactivities": 3000,
    "disposalofnoncurrentfinancialinstruments": 22768000,
    "cashflowsfromusedininvestingactivities": 20631000,
    "proceedsfromissuingshares": 395000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 2361000,
    "cashflowsfromusedinfinancingactivities": -1966000,
    "effectofexchangeratechangesoncashandcashequivalents": 274000,
    "increasedecreaseincashandcashequivalents": -13619000,
    "tradeandotherreceivables": 66111000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -13666000,
    "tradeandotherpayables": 17018000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -3893000,
    "collaborationliabilities": 52677000,
    "adjustmentsforincreasedecreaseincollaborationliabilities": -10534000,
    "deferredincomeincludingcontractliabilities": 10483000,
    "adjustmentsforincreasedecreaseindeferredincomeincludingcontractliabilities": -3998000,
    "changeinworkingcapital": 14067000,
    "numberofsharesissued": 80874653,
    "allocationofpriorperiodincomeloss": -58103000,
    "exerciseandsubscriptionofequityinstrumentsinshares": 648489,
    "exerciseandsubscriptionofequityinstruments": 32000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4256000,
    "disclosureofcompanysignificantcontractsandkeyeventstextblock": "The company",
    "descriptionofaccountingpolicyforbasisofpreparationpolicytextblock": "Basis of preparation",
    "descriptionofstatementofcompliancepolicytextblock": "Statement of compliance",
    "descriptionofaccountingpolicyfornewifrsreleasespolicytextblock": "Recently issued accounting standards and interpretations",
    "descriptionofaccountingpolicyforchangeinaccountingpoliciespolicytextblock": "<span style=\"color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%;padding-left:26.84pt\">Change in accounting policies</span>There has been no change in accounting policies for any of the years presented.",
    "descriptionofaccountingpolicyforconsolidationmethodpolicytextblock": "Consolidation method",
    "descriptionofaccountingpolicyforothercomprehensiveincomepolicytextblock": "Other comprehensive income",
    "descriptionofaccountingpolicyforaccountingestimatesandassumptionspolicytextblock": "Critical accounting estimates and assumptions",
    "disclosureofdepreciationperiodstabletextblock": "Depreciation periods are as follows:Buildings and improvements on buildings20to40 yearsInstallations5to20 yearsTechnical installations and equipment8 yearsEquipment and office furniture5 yearsComputers and IT equipment3 years",
    "disclosureofcashcashequivalentsandfinancialassetstextblock": "December 31(in thousands of euro)202120222023Cash and cash equivalents 103,756 84,225 70,605 Short-term investments16,080 17,260 21,851 Cash and cash equivalents and short-term investments119,836 101,485 92,456 Non-current financial assets39,878 35,119 9,796 Total cash, cash equivalents and financial assets159,714 136,604 102,252",
    "disclosureoftradepayablesandotherstextblock": "This line item is analyzed as follows:December 31,(in thousands of euro)202120222023Suppliers (excluding payables related to capital expenditures)14,729 13,656 8,561 Tax and employee-related payables7,463 5,978 7,021 Other payables (1)6,380 1,260 1,436 Trade payables and others excluding payables related to capital expenditures28,573 20,894 17,018 Payables related to capital expenditures— 17 — Payables and others28,573 20,911 17,018",
    "disclosureofchangeinnumberofotherequityinstrumentsoutstandingtabletextblock": "Change in Number of AGAs OutstandingYear ended December 31,Number of AGAs202120222023Balance at beginning of period2,752,198 3,678,354 4,677,173 Granted during the period1,802,348 2,188,521 2,341,793 Forfeited during the period(614,338)(567,330)(1,309,314)Exercised during the period(261,854)(622,372)(506,589)Expired during the period— — — Balance at end of period3,678,354 4,677,173 5,203,063",
    "disclosureofkeymanagementpersonnelcompensationtabletextblock": "For each of the periods presented, the following compensation was granted to the members of the Leadership Team of the Company and were recognized as expense:Year ended December 31,(in thousands of euro)202120222023Personnel expenses and other short-term employee benefits3,456 2,176 2,856 Extra pension benefits11 43 33 Share-based compensation2,067 1,989 2,081 Advisory fees — 661 471 Executive Committee members compensation5,534 4,869 5,441",
    "numberofclinicalproductcandidates": 7,
    "numberofwhollyownedsubsidiaries": 1,
    "financialliabilities": 20000000,
    "numberofexclusiveoptionsgranted": 2,
    "numberofpreclinicalmolecules": 2,
    "exerciseperiodterms": "P3Y",
    "numberoflicenseoptionsretained": 3,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 625000,
    "parvaluepershare": 0.05,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 2.04,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P1Y",
    "definedcontributionplancontributionpercentage": 0.022,
    "definedcontributionplancontributionpercentagebyemployer": 0.014,
    "definedcontributionplancontributionpercentagebyemployee": 0.008,
    "otherlongtermbenefitsyearsofservicethresholdone": "P10Y",
    "otherlongtermbenefitsyearsofservicethresholdtwo": "P15Y",
    "otherlongtermbenefitsyearsofservicethresholdthree": "P20Y",
    "percentageofworktobeperformed": 0.981,
    "averageforeignexchangerate": 1.0813,
    "closingforeignexchangerate": 1.105,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "cashcashequivalentandshortterminvestments": 92456000,
    "percentageofrevenuedenominatedinusdollars": 0.29,
    "percentageofpaymentsinusdollars": 0.43,
    "borrowingnumberofloanagreement": 2,
    "totalcashcashequivalentsandfinancialassets": 102252000,
    "currentinvestments": 21851000,
    "shortterminvestmentsacquisitions": 3950000,
    "shortterminvestmentsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 1010000,
    "increasedecreaseinaccruedinterestforcurrentfinancialassetsnotatfairvaluethroughprofitorloss": 174000,
    "shortterminvestmentsforeigncurrencyeffect": -544000,
    "decreasethroughderecognitionnoncurrentfinancialassets": 26718000,
    "noncurrentfinancialassetsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 582000,
    "increasedecreaseinaccruedinterestfornoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": 817000,
    "shortterminvestmentsandnoncurrentfinancialassets": 31647000,
    "totalacquisitions": 3950000,
    "decreasethroughderecognitionshortterminvestmentandnoncurrentfinancialassets": 26718000,
    "totalvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 1592000,
    "increasedecreaseinaccruedinterestforshorttermandnoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": 991000,
    "totalforeigncurrencyeffect": -544000,
    "othercurrentreceivables": 104000,
    "researchtaxcreditreceivablecurrent": 29755000,
    "othercurrenttaxcreditsreceivables": 360000,
    "currentprepaidexpenses": 5693000,
    "currentvalueaddedtaxreceivables": 1037000,
    "currenttradereceivables": 15233000,
    "currentadvancestosuppliers": 3374000,
    "tradeandothercurrentreceivablesexcludingrebates": 55557000,
    "noncurrentresearchtaxcredit": 9800000,
    "noncurrentprepaidexpenses": 754000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 2000000,
    "amortisationintangibleassetsotherthangoodwill": 3140000,
    "licensingagreementmaximummilestonepayment": 48200000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 101000,
    "disposalspropertyplantandequipment": 516000,
    "depreciationpropertyplantandequipment": 860000,
    "increasedecreasethroughtransferspropertyplantandequipment": -10000,
    "tradeandothercurrentpayablestotradesuppliers": 8561000,
    "payablesonsocialsecurityandtaxesotherthanincometax": 7021000,
    "othercurrentpayables": 1436000,
    "currenttradepayablesandothersexcludingpayablesrelatedtocapitalexpenditures": 17018000,
    "proceedsfromleaseliabilitiesclassifiedasfinancingactivities": -1000,
    "repaymentsofborrowingsandleaseliabilitiesnetofexchangeratevariationclassifiedasfinancingactivities": 293000,
    "borrowingsinterestrate": 0.0201,
    "writeoffofarightofuseasset": 500000,
    "writeoffofaleaseliability": 700000,
    "bankborrowingsundiscountedcashflows": 5167000,
    "definedbenefitobligationatpresentvalue": 2064000,
    "increasedecreaseinemployeebenefitobligationper25basispointchangesindiscountrate": 62000,
    "postemploymentbenefitexpensedefinedcontributionplans": 1283000,
    "actuarialassumptionofdiscountrates": 0.032,
    "actuarialassumptionofexpectedratesofsalaryincreases": 0.025,
    "annualmobilityrate": 0.052,
    "rateofcontributions": 0.4801,
    "rateofwagescosts": 0.2432,
    "actuarialassumptionofretirementage2019": "P64Y",
    "actuarialassumptionofannualturnoverratebyage1624years": 0.15,
    "actuarialassumptionofannualturnoverratebyage2529years": 0.14,
    "actuarialassumptionofannualturnoverratebyage3034years": 0.1,
    "actuarialassumptionofannualturnoverratebyage3539years": 0.06,
    "actuarialassumptionofannualturnoverratebyage4044years": 0.04,
    "actuarialassumptionofannualturnoverratebyage4549years": 0.02,
    "liabilityassetofdefinedbenefitplans": 2441000,
    "currentservicecostnetdefinedbenefitliabilityasset": 312000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": -27000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": 394000,
    "numberofsharesoutstanding": 80860563,
    "sharesinentityheldbyentityorbyitssubsidiariesorassociates": 18575,
    "expensefromsharebasedpaymenttransactionswithemployees": 1436000,
    "internalconditionsperformancerevenuefromcollaborationandlicensingagreementsminimumaccrualbetweenattributionanddefinitiveacquisitiondate": 100000000,
    "percentageofannualvariablecompensation": 0.5,
    "percentageofpremiumincreased": 0.5,
    "percentageofoverperformance": 1,
    "sharebasedpaymenttransactionswithemployeesawardsexpectedterm": "P10Y",
    "numberofenvironmentalorsocialactionsimplemented": 6,
    "numberofinstrumentsotherequityinstrumentsgranted": 650000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 25000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 1045722,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 1045722,
    "financialassets": 9796000,
    "financialassetsatfairvalue": 9796000,
    "financialliabilitiestradepayablesandothers": 30957000,
    "financialliabilitiestradepayablesandothersatfairvalue": 30957000,
    "increasethroughperformanceobligationbeingsatisfiedcontractliabilities": 34335000,
    "contractliabilities": 5156000,
    "decreasethroughperformanceobligationbeingsatisfiedcontractliabilities": 9499000,
    "transferfromtocollaborationliabilities": -173000,
    "increasethroughmilestonepaymentscontractliabilities": 50000000,
    "decreasethroughdeductionscontractliabilities": 10534000,
    "increasethroughupfrontpaymentcontractliabilities": 5000000,
    "incomefromresearchtaxcredit": 9729000,
    "subcontractingcosts": 27568000,
    "rawmaterialsandconsumablesused": 2611000,
    "shorttermemployeebenefitsexpense": 14834000,
    "employeebenefitsexpense": 17121000,
    "nonscientificadvisoryandconsulting": 732000,
    "leasingandmaintenance": 879000,
    "travelexpense": 380000,
    "salesandmarketingexpense": 52000,
    "scientificadvisoryandconsulting": 1220000,
    "otherpurchasesandexternalexpenses": 28000,
    "depreciationandamortisationexpense": 3891000,
    "intellectualpropertyexpenses": 1292000,
    "otheroperatingincomeexpense": -248000,
    "auditorsremunerationforauditservices": 725000,
    "auditorsremunerationforotherservices": 213000,
    "auditorsremuneration": 938000,
    "numberofemployees": 175,
    "interestsandgainsonfinancialassets": 3177000,
    "unrealizedgainsonfinancialassets": 1648000,
    "netforeignexchangegain": 2109000,
    "netforeignexchangeloss": 1195000,
    "interestexpense": 640000,
    "unusedtaxlosseswithnoexpirationdate": 483570000,
    "increasedecreaseunusedtaxlosses": -277000,
    "unusedtaxlossessubjecttoexpiration": 15181000,
    "unusedtaxlossessubjecttoexpirationperiod": "P20Y",
    "accountingprofit": -7570000,
    "applicabletaxrate": 0.25,
    "taxexpenseincomeatapplicabletaxrate": -1892000,
    "researchtaxcredit": 2457000,
    "taxeffectofdefinedbenefitobligations": -27000,
    "taxeffectofsharebasedcompensation": 1064000,
    "taxeffectofrevenuefromcollaborationswithcustomers": -1095000,
    "taxeffectofnonrecognitionofdeferredtaxassetsrelatedtotaxlossesandtemporarydifferences": 4501000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -94000,
    "noncancellableoffbalancesheetpurchasedcommitments": 5965000,
    "provisions": 774000,
    "provisionsforemployeebenefits": 565000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2856000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 33000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2081000,
    "keymanagementpersonnelcompensationadvisoryfees": 471000,
    "keymanagementpersonnelcompensation": 5441000,
    "numberofmembersoftheexecutivecommitteealsomembersoftheexecutiveboard": 2,
    "provisionforattendancefees": 353000,
    "cashadvancesandloansfromrelatedparties": 4724000,
    "amountsreceivablerelatedpartytransactions": 648000,
    "cashadvancesandloansmadetorelatedparties": 10911000,
    "amountspayablerelatedpartytransactions": 3301000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": 6187000,
    "netamountsreceivablepayablerelatedpartytransactions": -2653000,
    "weightedaverageshares": 80453282,
    "numberofinstrumentswithpotentialfuturedilutiveeffectnotincludedincalculationofdilutedearningspershare": 5145914
  },
  {
    "date": "2022-12-31",
    "symbol": "IPHYF",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39084",
    "entityregistrantname": "Innate Pharma SA",
    "entityincorporationstatecountrycode": "I0",
    "entityaddressaddressline1": "117, Avenue de Luminy",
    "entityaddresspostalzipcode": 13009,
    "entityaddresscityortown": "Marseille",
    "entityaddresscountry": "FR",
    "contactpersonnelname": "Mondher Mahjoubi, M.D.",
    "cityareacode": 33,
    "localphonenumber": "4 30 30 30 30",
    "security12btitle": "American Depositary Shares, each representing one ordinary share, nominal value €0.05 per share",
    "tradingsymbol": "IPHA",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 79542627,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1598599,
    "amendmentflag": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "auditorfirmid": 1756,
    "auditorname": "Deloitte & Associés",
    "auditorlocation": "Paris La Défense, France",
    "intangibleassetsotherthangoodwill": 1556000,
    "propertyplantandequipment": 8542000,
    "noncurrentfinancialassets": 35119000,
    "othernoncurrentnonfinancialassets": 149000,
    "noncurrentreceivables": 14099000,
    "deferredtaxassets": 8568000,
    "noncurrentassets": 68033000,
    "cashandcashequivalents": 84225000,
    "currentfinancialassets": 17260000,
    "tradeandothercurrentreceivables": 38346000,
    "currentassets": 139831000,
    "assets": 207863000,
    "issuedcapital": 4011000,
    "sharepremium": 379637000,
    "reservesandretainedearnings": -272213000,
    "otherreserves": 819000,
    "netincomeloss": -58103000,
    "equity": 54151000,
    "collaborationliabilitiesnoncurrentportion": 52988000,
    "noncurrentfinancialliabilities": 40149000,
    "noncurrentprovisionsforemployeebenefits": 2550000,
    "noncurrentdeferredincomeincludingnoncurrentcontractliabilities": 7921000,
    "noncurrentprovisions": 198000,
    "deferredtaxliabilities": 8568000,
    "noncurrentliabilities": 112374000,
    "tradeandothercurrentpayables": 20911000,
    "collaborationliabilitiescurrentportion": 10223000,
    "currentfinancialliabilities": 2102000,
    "currentdeferredincomeincludingcurrentcontractliabilities": 6560000,
    "currentprovisions": 1542000,
    "currentliabilities": 41338000,
    "equityandliabilities": 207863000,
    "revenuefromcontractswithcustomers": 49580000,
    "governmentfinancingforresearchexpenditures": 8035000,
    "otherincome": 59000,
    "revenue": 57674000,
    "researchanddevelopmentexpense": 51663000,
    "sellinggeneralandadministrativeexpense": 22436000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 41000000,
    "operatingexpense": 115099000,
    "profitlossfromoperatingactivities": -57425000,
    "financeincome": 4775000,
    "financecosts": 5321000,
    "financeincomecost": -546000,
    "profitlossbeforetax": -57972000,
    "profitlossfromcontinuingoperations": -57972000,
    "profitlossfromdiscontinuedoperations": -131000,
    "profitloss": -58103000,
    "basicearningslosspershare": -0.73,
    "dilutedearningslosspershare": -0.73,
    "basicearningslosspersharefromcontinuingoperations": -0.73,
    "dilutedearningslosspersharefromcontinuingoperations": -0.73,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -428000,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": 790000,
    "othercomprehensiveincome": 362000,
    "comprehensiveincome": -57741000,
    "adjustmentsfordepreciationandamortisationexpense": 45405000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 365000,
    "adjustmentsforprovisions": 839000,
    "adjustmentsforsharebasedpayments": 4249000,
    "adjustmentsforfairvaluegainslosses": 1372000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -912000,
    "changeinaccruedinterestsonfinancialassets": 118000,
    "otheradjustmentstoreconcileprofitloss": 15000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -6652000,
    "increasedecreaseinworkingcapital": 12502000,
    "cashflowsfromusedinoperatingactivities": -19154000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 587000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 535000,
    "purchaseofotherlongtermassetsclassifiedasinvestingactivities": 1000,
    "disposalofnoncurrentfinancialinstruments": 3000000,
    "cashflowsfromusedininvestingactivities": 1877000,
    "proceedsfromissuingshares": 198000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 2026000,
    "cashflowsfromusedinfinancingactivities": -1828000,
    "effectofexchangeratechangesoncashandcashequivalents": -428000,
    "increasedecreaseincashandcashequivalents": -19531000,
    "tradeandotherreceivables": 52445000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -4204000,
    "tradeandotherpayables": 20911000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -7662000,
    "collaborationliabilities": 63211000,
    "adjustmentsforincreasedecreaseincollaborationliabilities": 22796000,
    "deferredincomeincludingcontractliabilities": 14481000,
    "adjustmentsforincreasedecreaseindeferredincomeincludingcontractliabilities": -23432000,
    "changeinworkingcapital": 46158000,
    "numberofsharesissued": 80226164,
    "allocationofpriorperiodincomeloss": -52809000,
    "exerciseandsubscriptionofequityinstrumentsinshares": 669442,
    "exerciseandsubscriptionofequityinstruments": 34000,
    "increasedecreasethroughsharebasedpaymenttransactions": 4249000,
    "numberofwhollyownedsubsidiaries": 1,
    "financialliabilities": 20000000,
    "revenuefromcontractswithcustomersmilestonepaymentreceived": 50000000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 625000,
    "parvaluepershare": 0.05,
    "provisions": 1270000,
    "borrowingnumberofloanagreement": 2,
    "borrowingmaturity": "P5Y",
    "borrowingsinterestrate": 0.0201,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P1Y",
    "definedcontributionplancontributionpercentage": 0.022,
    "definedcontributionplancontributionpercentagebyemployer": 0.014,
    "definedcontributionplancontributionpercentagebyemployee": 0.008,
    "otherlongtermbenefitsyearsofservicethresholdone": "P10Y",
    "otherlongtermbenefitsyearsofservicethresholdtwo": "P15Y",
    "otherlongtermbenefitsyearsofservicethresholdthree": "P20Y",
    "percentageofworktobeperformed": 0.945,
    "averageforeignexchangerate": 1.053,
    "closingforeignexchangerate": 1.0666,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "cashcashequivalentsandshortterminvestments": 101485000,
    "percentageofrevenuedenominatedinusdollars": 0.92,
    "percentageofpaymentsinusdollars": 0.5,
    "totalcashcashequivalentsandfinancialassets": 136604000,
    "currentinvestments": 17260000,
    "shortterminvestmentsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 268000,
    "shortterminvestmentsforeigncurrencyeffect": 912000,
    "decreasethroughderecognitionnoncurrentfinancialassets": 3000000,
    "noncurrentfinancialassetsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": -1640000,
    "increasedecreaseinaccruedinterestfornoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": -118000,
    "shortterminvestmentsandnoncurrentfinancialassets": 52379000,
    "decreasethroughderecognitionshortterminvestmentandnoncurrentfinancialassets": 3000000,
    "totalvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": -1372000,
    "increasedecreaseinaccruedinterestforshorttermandnoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": -118000,
    "totalforeigncurrencyeffect": 912000,
    "othercurrentreceivables": 61000,
    "researchtaxcreditreceivablecurrent": 25904000,
    "othercurrenttaxcreditsreceivables": 361000,
    "currentprepaidexpenses": 4672000,
    "currentvalueaddedtaxreceivables": 1614000,
    "currenttradereceivables": 3080000,
    "currentadvancestosuppliers": 2652000,
    "tradeandothercurrentreceivablesexcludingrebates": 38345000,
    "noncurrentresearchtaxcredit": 13018000,
    "noncurrentprepaidexpenses": 1081000,
    "tradeandothernoncurrentreceivablesexcludingrebates": 14099000,
    "tradeandotherreceivablesexcludingrebates": 52445000,
    "incomefromresearchtaxcredit2022": 9167000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 587000,
    "amortisationintangibleassetsotherthangoodwill": 2195000,
    "licensingagreementmaximummilestonepayment": 48200000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 20000,
    "disposalspropertyplantandequipment": 11000,
    "depreciationpropertyplantandequipment": 759000,
    "tradeandothercurrentpayablestotradesuppliers": 13656000,
    "payablesonsocialsecurityandtaxesotherthanincometax": 5978000,
    "othercurrentpayables": 1260000,
    "currenttradepayablesandothersexcludingpayablesrelatedtocapitalexpenditures": 20894000,
    "currentpayablesrelatedtocapitalexpenditures": 17000,
    "proceedsfromleaseliabilitiesclassifiedasfinancingactivities": 15000,
    "repaymentsofborrowingsandleaseliabilitiesnetofexchangeratevariationclassifiedasfinancingactivities": 522000,
    "bankborrowingsundiscountedcashflows": 312000,
    "definedbenefitobligationatpresentvalue": 2184000,
    "increasedecreaseinemployeebenefitobligationper50basispointchangesindiscountrate": 174000,
    "postemploymentbenefitexpensedefinedcontributionplans": 1432000,
    "actuarialassumptionofdiscountrates": 0.0375,
    "actuarialassumptionofexpectedratesofsalaryincreases": 0.04,
    "annualmobilityrate": 0.043,
    "rateofcontributions": 0.4707,
    "rateofwagescosts": 0.2346,
    "actuarialassumptionofretirementage2019": "P64Y",
    "actuarialassumptionofannualturnoverratebyage1624years": 0.12,
    "actuarialassumptionofannualturnoverratebyage2529years": 0.1,
    "actuarialassumptionofannualturnoverratebyage3034years": 0.07,
    "actuarialassumptionofannualturnoverratebyage3539years": 0.05,
    "actuarialassumptionofannualturnoverratebyage4044years": 0.03,
    "actuarialassumptionofannualturnoverratebyage4549years": 0.015,
    "liabilityassetofdefinedbenefitplans": 2550000,
    "currentservicecostnetdefinedbenefitliabilityasset": 427000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": -62000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": 790000,
    "numberofsharesoutstanding": 79542627,
    "sharesinentityheldbyentityorbyitssubsidiariesorassociates": 18575,
    "expensefromsharebasedpaymenttransactionswithemployees": -181000,
    "percentageofannualvariablecompensation": 0.5,
    "percentageofpremiumincreased": 0.3,
    "internalconditionsperformancerevenuefromcollaborationandlicensingagreementsminimumaccrualbetweenattributionanddefinitiveacquisitiondate": 100000000,
    "sharebasedpaymenttransactionswithemployeesawardsexpectedterm": "P10Y",
    "numberofinstrumentsotherequityinstrumentsgranted": 650000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 25000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 59350,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 59350,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 2.04,
    "financialassets": 35119000,
    "financialassetsatfairvalue": 35119000,
    "financialliabilitiestradepayablesandothers": 40149000,
    "financialliabilitiestradepayablesandothersatfairvalue": 40149000,
    "contractliabilities": 14481000,
    "decreasethroughperformanceobligationbeingsatisfiedcontractliabilities": 22376000,
    "transferfromtocollaborationliabilities": 30989000,
    "increasethroughmilestonepaymentscontractliabilities": 47687000,
    "increasethroughdeductionscontractliabilities": 37564000,
    "decreasethroughdeductionscontractliabilities": 14768000,
    "decreaseindeferredincomeincludingcontractliabilities": 17400000,
    "increasethroughupfrontpaymentcontractliabilities": 47687000,
    "incomefromresearchtaxcredit": 7925000,
    "revenuefromgovernmentgrants": 110000,
    "subcontractingcosts": 24432000,
    "rawmaterialsandconsumablesused": 3051000,
    "shorttermemployeebenefitsexpense": 14329000,
    "employeebenefitsexpense": 16373000,
    "nonscientificadvisoryandconsulting": 1441000,
    "leasingandmaintenance": 200000,
    "travelexpense": 466000,
    "salesandmarketingexpense": 130000,
    "scientificadvisoryandconsulting": 1263000,
    "otherpurchasesandexternalexpenses": 91000,
    "depreciationandamortisationexpense": 2928000,
    "intellectualpropertyexpenses": 996000,
    "otheroperatingincomeexpense": -292000,
    "auditorsremunerationforauditservices": 855000,
    "auditorsremunerationforotherservices": 248000,
    "auditorsremuneration": 1103000,
    "shorttermemployeebenefitsexpensecontinuingactivities": 22354000,
    "numberofemployees": 208,
    "interestsandgainsonfinancialassets": 546000,
    "unrealizedgainsonfinancialassets": 418000,
    "netforeignexchangegain": 3810000,
    "netforeignexchangeloss": 2983000,
    "unrealizedlossesonfinancialassets": 2050000,
    "interestexpense": 288000,
    "unusedtaxlosseswithnoexpirationdate": 466153000,
    "unusedtaxlossessubjecttoexpiration": 15419000,
    "unusedtaxlossessubjecttoexpirationperiod": "P20Y",
    "accountingprofit": -58103000,
    "applicabletaxrate": 0.25,
    "taxexpenseincomeatapplicabletaxrate": -14526000,
    "researchtaxcredit": 1971000,
    "taxeffectofdefinedbenefitobligations": -106000,
    "taxeffectofsharebasedcompensation": 1062000,
    "taxeffectofrevenuefromcollaborationswithcustomers": -2210000,
    "taxeffectofnonrecognitionofdeferredtaxassetsrelatedtotaxlossesandtemporarydifferences": 18290000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -539000,
    "revenuefromsaleofgoods": 22000,
    "cashflowsfromusedinoperatingactivitiesdiscontinuedoperations": -5097000,
    "increasedecreaseincashandcashequivalentsdiscontinuedoperations": -5097000,
    "noncancellableoffbalancesheetpurchasedcommitments": 8774000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2176000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 43000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1989000,
    "keymanagementpersonnelcompensationadvisoryfees": 661000,
    "keymanagementpersonnelcompensation": 4869000,
    "numberofmembersoftheexecutivecommitteealsomembersoftheexecutiveboard": 2,
    "provisionforattendancefees": 348000,
    "cashadvancesandloansfromrelatedparties": 54774000,
    "amountsreceivablerelatedpartytransactions": 3078000,
    "cashadvancesandloansmadetorelatedparties": 17745000,
    "amountspayablerelatedpartytransactions": 7298000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": -37029000,
    "netamountsreceivablepayablerelatedpartytransactions": -4220000,
    "weightedaverageshares": 79639826,
    "numberofinstrumentswithpotentialfuturedilutiveeffectnotincludedincalculationofdilutedearningspershare": 2265301
  },
  {
    "date": "2021-12-31",
    "symbol": "IPHYF",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2021-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39084",
    "entityregistrantname": "Innate Pharma SA",
    "entityincorporationstatecountrycode": "I0",
    "entityaddressaddressline1": "117, Avenue de Luminy",
    "entityaddresspostalzipcode": 13009,
    "entityaddresscityortown": "Marseille",
    "entityaddresscountry": "FR",
    "contactpersonnelname": "Mondher Mahjoubi, M.D.",
    "cityareacode": 33,
    "localphonenumber": "4 30 30 30 30",
    "security12btitle": "American Depositary Shares, each representing one ordinary share, nominal value €0.05 per share",
    "tradingsymbol": "IPHA",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 79542627,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1598599,
    "amendmentflag": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2021,
    "auditorfirmid": 1756,
    "auditorname": "Deloitte & Associés",
    "auditorlocation": "Paris La Défense, France",
    "intangibleassetsotherthangoodwill": 44192000,
    "propertyplantandequipment": 10174000,
    "noncurrentfinancialassets": 39878000,
    "othernoncurrentnonfinancialassets": 148000,
    "noncurrentreceivables": 29821000,
    "deferredtaxassets": 5028000,
    "noncurrentassets": 129241000,
    "cashandcashequivalents": 103756000,
    "currentfinancialassets": 16080000,
    "tradeandothercurrentreceivables": 18420000,
    "currentassets": 138256000,
    "assets": 267496000,
    "issuedcapital": 3978000,
    "sharepremium": 375220000,
    "reservesandretainedearnings": -219404000,
    "otherreserves": 456000,
    "netincomeloss": -52809000,
    "equity": 107440000,
    "collaborationliabilitiesnoncurrentportion": 32997000,
    "noncurrentfinancialliabilities": 13503000,
    "noncurrentprovisionsforemployeebenefits": 2975000,
    "noncurrentdeferredincomeincludingnoncurrentcontractliabilities": 25413000,
    "noncurrentprovisions": 253000,
    "deferredtaxliabilities": 5028000,
    "noncurrentliabilities": 80169000,
    "tradeandothercurrentpayables": 28573000,
    "collaborationliabilitiescurrentportion": 7418000,
    "currentfinancialliabilities": 30748000,
    "currentdeferredincomeincludingcurrentcontractliabilities": 12500000,
    "currentprovisions": 647000,
    "currentliabilities": 79886000,
    "equityandliabilities": 267496000,
    "revenuefromcontractswithcustomers": 12112000,
    "governmentfinancingforresearchexpenditures": 12591000,
    "revenue": 24703000,
    "researchanddevelopmentexpense": 47004000,
    "sellinggeneralandadministrativeexpense": 25524000,
    "operatingexpense": 72528000,
    "profitlossfromoperatingactivities": -47825000,
    "financeincome": 6344000,
    "financecosts": 3997000,
    "financeincomecost": 2347000,
    "profitlossbeforetax": -45478000,
    "profitlossfromcontinuingoperations": -45478000,
    "profitlossfromdiscontinuedoperations": -7331000,
    "profitloss": -52809000,
    "basicearningslosspershare": -0.66,
    "dilutedearningslosspershare": -0.66,
    "basicearningslosspersharefromcontinuingoperations": -0.57,
    "dilutedearningslosspersharefromcontinuingoperations": -0.57,
    "basicearningslosspersharefromdiscontinuedoperations": -0.09,
    "dilutedearningslosspersharefromdiscontinuedoperations": -0.09,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": -483000,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": 584000,
    "othercomprehensiveincome": 101000,
    "comprehensiveincome": -52708000,
    "adjustmentsfordepreciationandamortisationexpense": 4596000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 437000,
    "adjustmentsforprovisions": 4000,
    "adjustmentsforsharebasedpayments": 2617000,
    "adjustmentsforfairvaluegainslosses": -987000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -1136000,
    "changeinaccruedinterestsonfinancialassets": -55000,
    "adjustmentsforfinanceincome": 367000,
    "adjustmentsforfinancecosts": 312000,
    "otheradjustmentstoreconcileprofitloss": -1185000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -48573000,
    "increasedecreaseinworkingcapital": 9884000,
    "cashflowsfromusedinoperatingactivities": -58457000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 401000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 929000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 7000,
    "proceedsfromotherlongtermassetsclassifiedasinvestingactivities": 40000,
    "purchaseofotherlongtermassetsclassifiedasinvestingactivities": 1000,
    "interestreceivedclassifiedasinvestingactivities": 367000,
    "cashflowsfromusedininvestingactivities": -917000,
    "proceedsfromissuingshares": 499000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 28700000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 2069000,
    "interestpaidclassifiedasfinancingactivities": 312000,
    "cashflowsfromusedinfinancingactivities": 26818000,
    "effectofexchangeratechangesoncashandcashequivalents": -483000,
    "increasedecreaseincashandcashequivalents": -33037000,
    "tradeandotherreceivables": 48241000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 3394000,
    "tradeandotherpayables": 28573000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -946000,
    "collaborationliabilities": 40415000,
    "adjustmentsforincreasedecreaseincollaborationliabilities": -6271000,
    "deferredincomeincludingcontractliabilities": 37913000,
    "adjustmentsforincreasedecreaseindeferredincomeincludingcontractliabilities": -6060000,
    "changeinworkingcapital": 58660000,
    "numberofsharesissued": 79556722,
    "allocationofpriorperiodincomeloss": -63984000,
    "exerciseandsubscriptionofequityinstrumentsinshares": 555770,
    "exerciseandsubscriptionofequityinstruments": 28000,
    "increasedecreasethroughsharebasedpaymenttransactions": 2617000,
    "numberofclinicalproductcandidates": 6,
    "numberofwhollyownedsubsidiaries": 1,
    "financialliabilities": 20000000,
    "maximumpaymentstocounterpartyuponachievementofcertainmilestones": 48800000,
    "revenuefromgovernmentgrants": 1988000,
    "parvaluepershare": 0.05,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 625000,
    "numberofinstrumentsotherequityinstrumentsgranted": 650000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P1Y",
    "definedcontributionplancontributionpercentage": 0.022,
    "definedcontributionplancontributionpercentagebyemployer": 0.014,
    "definedcontributionplancontributionpercentagebyemployee": 0.008,
    "otherlongtermbenefitsyearsofservicethresholdone": "P10Y",
    "otherlongtermbenefitsyearsofservicethresholdtwo": "P15Y",
    "otherlongtermbenefitsyearsofservicethresholdthree": "P20Y",
    "averageforeignexchangerate": 1.1827,
    "closingforeignexchangerate": 1.1326,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "cashcashequivalentsandshortterminvestments": 119836000,
    "percentageofrevenuedenominatedinusdollars": 0.78,
    "percentageofpaymentsinusdollars": 0.5,
    "totalcashcashequivalentsandfinancialassets": 159714000,
    "currentinvestments": 16080000,
    "shortterminvestmentsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 99000,
    "shortterminvestmentsforeigncurrencyeffect": 1136000,
    "noncurrentfinancialassetsvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 888000,
    "increasedecreaseinaccruedinterestfornoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": 55000,
    "shortterminvestmentsandnoncurrentfinancialassets": 55958000,
    "totalvariationoffairvaluethroughtheconsolidatedstatementofincomeloss": 987000,
    "increasedecreaseinaccruedinterestforshorttermandnoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": 55000,
    "totalforeigncurrencyeffect": 1136000,
    "othercurrentreceivables": 814000,
    "researchtaxcreditreceivablecurrent": 10310000,
    "othercurrenttaxcreditsreceivables": 333000,
    "currentprepaidexpenses": 2582000,
    "currentvalueaddedtaxreceivables": 1170000,
    "currenttradereceivables": 846000,
    "currentadvancestosuppliers": 2364000,
    "tradeandothercurrentreceivablesexcludingrebates": 18420000,
    "noncurrentresearchtaxcredit": 29821000,
    "tradeandothernoncurrentreceivablesexcludingrebates": 29821000,
    "tradeandotherreceivablesexcludingrebates": 48241000,
    "incomefromresearchtaxcredit2021": 10302000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 13000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 368000,
    "disposalsintangibleassetsotherthangoodwill": 39000,
    "amortisationintangibleassetsotherthangoodwill": 2310000,
    "discountrateusedincurrentmeasurementoffairvaluelesscostsofdisposal": 0.11,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 11000,
    "disposalspropertyplantandequipment": 7000,
    "increasedecreasethroughtransferspropertyplantandequipment": 4000,
    "depreciationpropertyplantandequipment": 781000,
    "tradeandothercurrentpayablestotradesuppliers": 14729000,
    "payablesonsocialsecurityandtaxesotherthanincometax": 7463000,
    "othercurrentpayables": 6380000,
    "currenttradepayablesandothersexcludingpayablesrelatedtocapitalexpenditures": 28573000,
    "proceedsfromleaseliabilitiesclassifiedasfinancingactivities": -1454000,
    "repaymentsofborrowingsandleaseliabilitiesnetofexchangeratevariationclassifiedasfinancingactivities": 150000,
    "borrowingsinterestrate": 0.0201,
    "bankborrowingsundiscountedcashflows": 20100000,
    "definedbenefitobligationatpresentvalue": 2544000,
    "increasedecreaseinemployeebenefitobligationper50basispointchangesindiscountrate": 188000,
    "postemploymentbenefitexpensedefinedcontributionplans": 1434000,
    "actuarialassumptionofdiscountrates": 0.0095,
    "actuarialassumptionofexpectedratesofsalaryincreases": 0.03,
    "annualmobilityrate": 0.042,
    "rateofcontributions": 0.4839,
    "rateofwagescosts": 0.2418,
    "actuarialassumptionofretirementage2019": "P64Y",
    "actuarialassumptionofannualturnoverratebyage1624years": 0.12,
    "actuarialassumptionofannualturnoverratebyage2529years": 0.09,
    "actuarialassumptionofannualturnoverratebyage3034years": 0.07,
    "actuarialassumptionofannualturnoverratebyage3539years": 0.045,
    "actuarialassumptionofannualturnoverratebyage4044years": 0.03,
    "actuarialassumptionofannualturnoverratebyage4549years": 0.015,
    "liabilityassetofdefinedbenefitplans": 2976000,
    "currentservicecostnetdefinedbenefitliabilityasset": 484000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": -47000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": 584000,
    "numberofsharesoutstanding": 79542627,
    "sharesinentityheldbyentityorbyitssubsidiariesorassociates": 18575,
    "expensefromsharebasedpaymenttransactionswithemployees": -232000,
    "percentageofannualvariablecompensation": 0.5,
    "percentageofpremiumincreased": 0.3,
    "internalconditionsperformancerevenuefromcollaborationandlicensingagreementsminimumaccrualbetweenattributionanddefinitiveacquisitiondate": 100000000,
    "sharebasedpaymenttransactionswithemployeesawardsexpectedterm": "P10Y",
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 25000,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 60100,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 60100,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 2.04,
    "numberofotherequityinstrumentsexpiredinsharebasedpaymentarrangement": 25000,
    "financialassets": 39878000,
    "financialassetsatfairvalue": 39878000,
    "financialliabilitiestradepayablesandothers": 13503000,
    "financialliabilitiestradepayablesandothersatfairvalue": 13503000,
    "contractliabilities": 20159000,
    "decreasethroughperformanceobligationbeingsatisfiedcontractliabilities": 7497000,
    "transferfromtocollaborationliabilities": -1084000,
    "increasethroughdeductionscontractliabilities": 4262000,
    "decreasethroughdeductionscontractliabilities": 10534000,
    "increasethroughupfrontpaymentcontractliabilities": 353000,
    "incomefromresearchtaxcredit": 10310000,
    "subcontractingcosts": 24189000,
    "rawmaterialsandconsumablesused": 2533000,
    "shorttermemployeebenefitsexpense": 14859000,
    "employeebenefitsexpense": 15208000,
    "nonscientificadvisoryandconsulting": 161000,
    "leasingandmaintenance": 260000,
    "travelexpense": 103000,
    "salesandmarketingexpense": 79000,
    "scientificadvisoryandconsulting": 288000,
    "otherpurchasesandexternalexpenses": 30000,
    "depreciationandamortisationexpense": 3153000,
    "intellectualpropertyexpenses": 1279000,
    "otheroperatingincomeexpense": 279000,
    "auditorsremunerationforauditservices": 702000,
    "auditorsremunerationforotherservices": 78000,
    "auditorsremuneration": 780000,
    "shorttermemployeebenefitsexpensecontinuingactivities": 25717000,
    "shorttermemployeebenefitsexpensediscontinuedactivities": 2242000,
    "numberofemployees": 214,
    "interestsandgainsonfinancialassets": 327000,
    "unrealizedgainsonfinancialassets": 1177000,
    "netforeignexchangegain": 4839000,
    "netforeignexchangeloss": 3591000,
    "unrealizedlossesonfinancialassets": 95000,
    "interestexpense": 312000,
    "unusedtaxlosseswithnoexpirationdate": 392359000,
    "unusedtaxlossessubjecttoexpiration": 14198000,
    "unusedtaxlossessubjecttoexpirationperiod": "P20Y",
    "accountingprofit": -52809000,
    "applicabletaxrate": 0.265,
    "taxexpenseincomeatapplicabletaxrate": -13994000,
    "differencesintaxrates": 62000,
    "researchtaxcredit": 3091000,
    "taxeffectofdefinedbenefitobligations": -39000,
    "taxeffectofsharebasedcompensation": 694000,
    "taxeffectofrevenuefromcollaborationswithcustomers": 3313000,
    "taxeffectofnonrecognitionofdeferredtaxassetsrelatedtotaxlossesandtemporarydifferences": 14433000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -1254000,
    "revenuefromsaleofgoods": 874000,
    "cashflowsfromusedinoperatingactivitiesdiscontinuedoperations": -3552000,
    "increasedecreaseincashandcashequivalentsdiscontinuedoperations": -3552000,
    "noncancellableoffbalancesheetpurchasedcommitments": 7134000,
    "provisions": 900000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3456000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 11000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2067000,
    "keymanagementpersonnelcompensation": 5534000,
    "numberofmembersoftheexecutivecommitteealsomembersoftheexecutiveboard": 2,
    "provisionforattendancefees": 338000,
    "cashadvancesandloansfromrelatedparties": 5317000,
    "amountsreceivablerelatedpartytransactions": 988000,
    "cashadvancesandloansmadetorelatedparties": 13030000,
    "amountspayablerelatedpartytransactions": 9522000,
    "cashrepaymentsofadvancesandloansfromrelatedparties": 7713000,
    "netamountsreceivablepayablerelatedpartytransactions": -8534000,
    "weightedaverageshares": 79542627,
    "numberofinstrumentswithpotentialfuturedilutiveeffectnotincludedincalculationofdilutedearningspershare": 2166829
  },
  {
    "date": "2020-12-31",
    "symbol": "IPHYF",
    "period": "FY",
    "documenttype": "20-F",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documentperiodenddate": "2020-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-39084",
    "entityregistrantname": "Innate Pharma SA",
    "entityincorporationstatecountrycode": "I0",
    "entityaddressaddressline1": "117, Avenue de Luminy",
    "entityaddresspostalzipcode": 13009,
    "entityaddresscityortown": "Marseille",
    "entityaddresscountry": "FR",
    "contactpersonnelname": "Mondher Mahjoubi, M.D.",
    "cityareacode": 33,
    "localphonenumber": "4 30 30 30 30",
    "security12btitle": "American Depositary Shares, each representing one ordinary share, nominal value €0.05 per share",
    "tradingsymbol": "IPHA",
    "securityexchangename": "NASDAQ",
    "entitycommonstocksharesoutstanding": 78986490,
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1598599,
    "amendmentflag": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "intangibleassetsotherthangoodwill": 46289000,
    "propertyplantandequipment": 11694000,
    "noncurrentfinancialassets": 38934000,
    "othernoncurrentnonfinancialassets": 147000,
    "noncurrentreceivables": 29821000,
    "deferredtaxassets": 7087000,
    "noncurrentassets": 133972000,
    "cashandcashequivalents": 136792000,
    "currentfinancialassets": 14845000,
    "tradeandothercurrentreceivables": 21814000,
    "currentassets": 173451000,
    "assets": 307423000,
    "issuedcapital": 3950000,
    "sharepremium": 372131000,
    "reservesandretainedearnings": -156476000,
    "otherreserves": 355000,
    "netincomeloss": -63984000,
    "equity": 155976000,
    "collaborationliabilitiesnoncurrentportion": 44854000,
    "noncurrentfinancialliabilities": 16945000,
    "noncurrentprovisionsforemployeebenefits": 4177000,
    "deferredincomeclassifiedasnoncurrent": 32674000,
    "noncurrentprovisions": 221000,
    "deferredtaxliabilities": 7087000,
    "noncurrentliabilities": 105959000,
    "tradeandothercurrentpayables": 29539000,
    "collaborationliabilitiescurrentportion": 1832000,
    "currentfinancialliabilities": 2142000,
    "deferredincomeclassifiedascurrent": 11299000,
    "currentprovisions": 676000,
    "currentliabilities": 45488000,
    "equityandliabilities": 307423000,
    "revenuefromcontractswithcustomers": 56155000,
    "governmentfinancingforresearchexpenditures": 13618000,
    "revenuefromsaleofgoods": 678000,
    "revenue": 70451000,
    "researchanddevelopmentexpense": 58613000,
    "sellinggeneralandadministrativeexpense": 31246000,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": 43529000,
    "operatingexpense": 133388000,
    "netincomelossfromdistributionagreements": 861000,
    "profitlossfromoperatingactivities": -62076000,
    "financeincome": 4855000,
    "financecosts": 6763000,
    "netfinancialincomecost": -1908000,
    "profitlossbeforetax": -63984000,
    "profitloss": -63984000,
    "basicearningslosspershare": -0.81,
    "dilutedearningslosspershare": -0.81,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 222000,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": -200000,
    "othercomprehensiveincome": 22000,
    "comprehensiveincome": -63962000,
    "adjustmentsfordepreciationandamortisationexpense": 56797000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 216000,
    "adjustmentsforprovisions": 604000,
    "adjustmentsforsharebasedpayments": 2475000,
    "adjustmentsforfairvaluegainslosses": 577000,
    "adjustmentsforunrealisedforeignexchangelossesgains": 1256000,
    "changeinaccruedinterestsonfinancialassets": 372000,
    "adjustmentsforfinanceincome": 962000,
    "adjustmentsforfinancecosts": 341000,
    "otheradjustmentstoreconcileprofitloss": -254000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -2562000,
    "increasedecreaseinworkingcapital": 49206000,
    "cashflowsfromusedinoperatingactivities": -51767000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 10375000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 907000,
    "purchaseoffinancialinstrumentsclassifiedasinvestingactivities": 3000000,
    "proceedsfromsalesofpropertyplantandequipmentclassifiedasinvestingactivities": 9000,
    "purchaseofotherlongtermassetsclassifiedasinvestingactivities": 59000,
    "interestreceivedclassifiedasinvestingactivities": 962000,
    "cashflowsfromusedininvestingactivities": -13370000,
    "proceedsfromissuingshares": 48000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 1360000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 2245000,
    "interestpaidclassifiedasfinancingactivities": 341000,
    "cashflowsfromusedinfinancingactivities": -1177000,
    "effectofexchangeratechangesoncashandcashequivalents": 219000,
    "increasedecreaseincashandcashequivalents": -66096000,
    "tradeandotherreceivables": 51635000,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -22919000,
    "tradeandotherpayables": 29519000,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -6528000,
    "collaborationliabilities": 46686000,
    "adjustmentsforincreasedecreaseincollaborationliabilities": 25382000,
    "deferredincome": 43973000,
    "adjustmentsforincreasedecreaseindeferredincome": -45139000,
    "changeinworkingcapital": 68543000,
    "numberofsharesissued": 79000952,
    "allocationofpriorperiodincome": -20759000,
    "exerciseandsubscriptionofequityinstrumentsinshares": 175331,
    "exerciseandsubscriptionofequityinstruments": 9000,
    "increasedecreasethroughsharebasedpaymenttransactions": 2476000,
    "numberofwhollyownedsubsidiaries": 1,
    "financialliabilities": 150000,
    "maximumpaymentstocounterpartyuponachievementofcertainmilestones": 49000000,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 395000,
    "parvaluepershare": 0.05,
    "numberofinstrumentsotherequityinstrumentsgranted": 650000,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P1Y",
    "definedcontributionplancontributionpercentage": 0.022,
    "definedcontributionplancontributionpercentagebyemployer": 0.014,
    "definedcontributionplancontributionpercentagebyemployee": 0.008,
    "otherlongtermbenefitsyearsofservicethresholdone": "P10Y",
    "otherlongtermbenefitsyearsofservicethresholdtwo": "P15Y",
    "otherlongtermbenefitsyearsofservicethresholdthree": "P20Y",
    "financeincomecost": -1908000,
    "averageforeignexchangerate": 1.1422,
    "closingforeignexchangerate": 1.2271,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P20Y",
    "cashcashequivalentsandshortterminvestments": 151637000,
    "percentageofrevenuedenominatedinusdollars": 0.88,
    "percentageofpaymentsinusdollars": 0.484,
    "totalcashcashequivalentsandfinancialassets": 190571000,
    "currentinvestments": 14845000,
    "shortterminvestmentsvariationoffairvaluethroughtheconsolidatedstatementofincome": 123000,
    "shortterminvestmentsforeigncurrencyeffect": -1256000,
    "noncurrentfinancialassetsacquisitions": 3000000,
    "noncurrentfinancialassetsvariationoffairvaluethroughtheconsolidatedstatementofincome": -700000,
    "interestincomefornoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": -372000,
    "shortterminvestmentsandnoncurrentfinancialassets": 53779000,
    "totalacquisitions": 3000000,
    "totalvariationoffairvaluethroughtheconsolidatedstatementofincome": -577000,
    "interestincomeforshorttermandnoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": -372000,
    "totalforeigncurrencyeffect": -1256000,
    "othercurrentreceivables": 741000,
    "othercurrenttaxcreditsreceivables": 333000,
    "currentprepaidexpenses": 6833000,
    "currentvalueaddedtaxreceivables": 2208000,
    "currenttradereceivables": 10585000,
    "currentadvancestosuppliers": 1114000,
    "tradeandothercurrentreceivablesexcludingrebates": 21815000,
    "noncurrentresearchtaxcredit": 29821000,
    "tradeandothernoncurrentreceivablesexcludingrebates": 29821000,
    "tradeandotherreceivablesexcludingrebates": 51635000,
    "incomefromresearchtaxcredit2020": 13084000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 264000,
    "amortisationintangibleassetsotherthangoodwill": 10904000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 3685000,
    "increasedecreasethroughotherchangesintangibleassetsotherthangoodwill": 1575000,
    "discountrateusedincurrentmeasurementoffairvaluelesscostsofdisposal": 0.12,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 1152000,
    "disposalspropertyplantandequipment": 9000,
    "increasedecreasethroughtransferspropertyplantandequipment": 134000,
    "depreciationpropertyplantandequipment": 757000,
    "tradeandothercurrentpayablestotradesuppliers": 20730000,
    "payablesonsocialsecurityandtaxesotherthanincometax": 8325000,
    "othercurrentpayables": 463000,
    "currenttradepayablesandothersexcludingpayablesrelatedtocapitalexpenditures": 29519000,
    "currentpayablesrelatedtocapitalexpenditures": 20000,
    "proceedsfromleaseliabilities": 94000,
    "decreaseindownpayment": 74000,
    "advances": 1454000,
    "borrowingsinterestrate": 0.0201,
    "bankborrowingsundiscountedcashflows": 150000,
    "definedbenefitobligationatpresentvalue": 3713000,
    "increasedecreaseinemployeebenefitobligationper50basispointchangesindiscountrate": 328000,
    "postemploymentbenefitexpensedefinedcontributionplans": 1420000,
    "actuarialassumptionofdiscountrates": 0.005,
    "actuarialassumptionofexpectedratesofsalaryincreases": 0.03,
    "annualmobilityrate": 0.026,
    "rateofcontributions": 0.4517,
    "rateofwagescosts": 0.2206,
    "actuarialassumptionofretirementage2019": "P64Y",
    "actuarialassumptionofannualturnoverratebyage1624years": 0.06,
    "actuarialassumptionofannualturnoverratebyage2529years": 0.05,
    "actuarialassumptionofannualturnoverratebyage3034years": 0.037,
    "actuarialassumptionofannualturnoverratebyage3539years": 0.03,
    "actuarialassumptionofannualturnoverratebyage4044years": 0.02,
    "actuarialassumptionofannualturnoverratebyage4549years": 0.01,
    "liabilityassetofdefinedbenefitplans": 4177000,
    "currentservicecostnetdefinedbenefitliabilityasset": 252000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": -35000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": -200000,
    "numberofsharesoutstanding": 78986490,
    "convertiblepreferredsharesvestingperiod": "P1Y",
    "convertiblepreferredsharesretentionperiod": "P2Y",
    "sharesinentityheldbyentityorbyitssubsidiariesorassociates": 18575,
    "expensefromsharebasedpaymenttransactionswithemployees": 618000,
    "percentageofannualvariablecompensation": 0.5,
    "percentageofpremiumincreased": 0.3,
    "sharebasedpaymenttransactionswithemployeesawardsexpectedterm": "P10Y",
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 2720,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 255000,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 255000,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 2.04,
    "financialassets": 38934000,
    "financialassetsatfairvalue": 38934000,
    "financialliabilitiestradepayablesandothers": 16945000,
    "financialliabilitiestradepayablesandothersatfairvalue": 16945000,
    "contractliabilities": 26572000,
    "decreasethroughperformanceobligationbeingsatisfiedcontractliabilities": 33620000,
    "transferfromcollaborationliabilities": 2465000,
    "increasethroughadditionscontractliabilities": 46320000,
    "decreasethroughdeductionscontractliabilities": 20938000,
    "increasethroughupfrontpaymentcontractliabilities": 4365000,
    "revenuefromcontractswithcustomersmilestone": 4365000,
    "incomefromresearchtaxcredit": 13084000,
    "revenuefromgovernmentgrants": 534000,
    "subcontractingcosts": 24355000,
    "rawmaterialsandconsumablesused": 3638000,
    "shorttermemployeebenefitsexpense": 14394000,
    "employeebenefitsexpense": 15230000,
    "nonscientificadvisoryandconsulting": 342000,
    "leasingandmaintenance": 579000,
    "travelexpense": 151000,
    "salesandmarketingexpense": 96000,
    "scientificadvisoryandconsulting": 945000,
    "otherpurchasesandexternalexpenses": 46000,
    "depreciationandamortisationexpense": 12006000,
    "intellectualpropertyexpenses": 882000,
    "otheroperatingincomeexpense": -343000,
    "auditorsremunerationforauditservices": 684000,
    "auditorsremunerationforotherservices": 115000,
    "auditorsremuneration": 799000,
    "numberofemployees": 237,
    "interestsandgainsonfinancialassets": 564000,
    "unrealizedgainsonfinancialassets": 313000,
    "netforeignexchangegain": 3978000,
    "netforeignexchangeloss": 5557000,
    "unrealizedlossesonfinancialassets": 865000,
    "interestexpense": 341000,
    "unusedtaxlosseswithnoexpirationdate": 287739000,
    "unusedtaxlossessubjecttoexpiration": 11955000,
    "unusedtaxlossessubjecttoexpirationperiod": "P20Y",
    "accountingprofit": -63984000,
    "applicabletaxrate": 0.28,
    "taxexpenseincomeatapplicabletaxrate": -17916000,
    "differencesintaxrates": 128000,
    "researchtaxcredit": 3961000,
    "taxeffectofdefinedbenefitobligations": 117000,
    "taxeffectofsharebasedcompensation": 693000,
    "taxeffectofrevenuefromcollaborationswithcustomers": -8824000,
    "taxeffectofnonrecognitionofdeferredtaxassetsrelatedtotaxlossesandtemporarydifferences": 15746000,
    "taxeffectofintragroupmergeroperations": 16288000,
    "taxeffectofexerciseofrealestateleasingoption": 1103000,
    "othertaxeffectsforreconciliationbetweenaccountingprofitandtaxexpenseincome": -3118000,
    "noncancellableoffbalancesheetpurchasedcommitments": 2896000,
    "estimatedmanufacturingcosts": 12800000,
    "provisions": 897000,
    "otherprovisions": 457000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 3131000,
    "keymanagementpersonnelcompensationsharebasedpayment": 1363000,
    "keymanagementpersonnelcompensation": 4494000,
    "provisionforattendancefees": 305000,
    "amountspayablerelatedpartytransactions": 4871000,
    "cashadvancesandloansfromrelatedparties": 57777000,
    "amountsreceivablerelatedpartytransactions": 2323000,
    "cashadvancesandloansmadetorelatedparties": 40254000,
    "cashreceiptsfromrepaymentofadvancesandloansmadetorelatedparties": 17523000,
    "netamountsreceivablepayablerelatedpartytransactions": -2548000,
    "weightedaverageshares": 78934960,
    "numberofinstrumentswithpotentialfuturedilutiveeffectnotincludedincalculationofdilutedearningspershare": 1564662
  },
  {
    "date": "2019-12-31",
    "symbol": "IPHYF",
    "period": "FY",
    "entityregistrantname": "Innate Pharma SA",
    "entitycentralindexkey": 1598599,
    "tradingsymbol": "inpha",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityinteractivedatacurrent": "Yes",
    "entitycommonstocksharesoutstanding": 78580464,
    "entityshellcompany": "false",
    "documenttype": "20-F",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12btitle": "Ordinary shares, nominal value &#x20ac;0.05 per share",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "profitloss": -20759000,
    "equity": -20759000,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 64130000,
    "financialliabilities": 18723000,
    "intangibleassetsotherthangoodwill": 96968000,
    "revenuefromcontractswithcustomers": 10000,
    "maximumpaymentstocounterpartyuponachievementofcertainmilestones": 51500000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 13900000,
    "otherreserves": -472000,
    "retainedearnings": -134912000,
    "cashcashequivalentsandshortterminvestments": 218865000,
    "percentageofrevenuedenomiatedinusdollars": 1,
    "percentageofpaymentsinusdollars": 0.151,
    "cashcashequivalentsandfinancialassets": 255869000,
    "othercurrentreceivables": 544000,
    "currentreceivablesfromtaxesotherthanincometax": 16737000,
    "rebaterelatedtocapitalexpenditures": 7580000,
    "rebaterelatedtocapitalexpendituresincreasedecreaseduringperiod": -7420000,
    "accruedreceivablesexcludingrebates": 691000,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 27020000,
    "considerationpaidreceived": 13565000,
    "amortisationintangibleassetsotherthangoodwill": 14502000,
    "changesinintangibleassetsotherthangoodwill": 4452000,
    "discountrateusedincurrentmeasurementoffairvaluelesscostsofdisposal": 0.12,
    "borrowingsinterestrate": 0.0201,
    "financialliabilitiesatfairvalue": 16825000,
    "otherlongtermbenefits": 479000,
    "increasedecreaseinemployeebenefitobligationper50basispointchangesindiscountrate": 286000,
    "postemploymentbenefitexpensedefinedcontributionplans": 1375000,
    "issuedcapital": 3941281.05,
    "numberofsharesissued": 14507,
    "parvaluepershare": 0.05,
    "convertiblepreferredsharesvestingperiod": "P1Y",
    "convertiblepreferredsharesretentionperiod": "P2Y",
    "paymentsforshareissuecosts": 621000,
    "paymentsfortheissuingofshares": 2150000,
    "treasuryshares": 18575,
    "expensefromsharebasedpaymenttransactionswithemployees": 2825000,
    "percentgeofannualvariablecompensation": 0.5,
    "percentageofpremiumincreased": 0.3,
    "sharebasedpaymenttransactionswithemployeesawardsexpectedterm": "P10Y",
    "socialsecuritycontributions": 569000,
    "revenuefavorablecumulativeadjustment": 38321000,
    "deferredincome": 89112000,
    "collaborationliabilities": 21304000,
    "currentcollaborationliabilities": 21304000,
    "deferredincomeclassifiedascurrent": 48770000,
    "deferredincomeclassifiedasnoncurrent": 40342000,
    "shorttermemployeebenefitsexpense": 7747000,
    "numberofemployees": 235,
    "rawmaterialsandconsumablesused": 3208000,
    "intellectualpropertyexpenses": 932000,
    "netincomelossfromdistributionagreements": 8219000,
    "unusedtaxlosseswithnoexpiration": 231167000,
    "unusedtaxlossessubjecttoexpiration": 5098000,
    "consumablepurchasescommitment": 93000,
    "provisions": 256000,
    "provisionforattendancefees": 274000,
    "amountspayablerelatedpartytransactions": 36296000,
    "researchanddevelopmentexpense": 78844000,
    "numberofinstrumentswithpotentialfuturedilutiveeffectnotincludedincalculationofdilutedearningspershare": 4810448,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "liabilityassetofdefinedbenefitplans": 3760000,
    "currentservicecostnetdefinedbenefitliabilityasset": 630000,
    "interestexpenseincomenetdefinedbenefitliabilityasset": 55000,
    "gainlossonremeasurementofnetdefinedbenefitliabilityasset": 622000,
    "contractliabilities": 89112000,
    "decreasethroughperformanceobligationbeingsatisfiedcontractliabilities": 61356000,
    "decreasethroughtransfertocollaborationliabilitiescontractliabilities": -273000,
    "decreasethroughdeductionscontractliabilities": 10352000,
    "currentinvestments": 15978000,
    "gainslossesoncurrentfinancialassetsatfairvaluethroughprofitorloss": 481000,
    "interestincomeforcurrentfinancialassetsnotatfairvaluethroughprofitorloss": -280000,
    "increasedecreasethroughforeignexchangeandothermovementscurrentfinancialassets": 15978000,
    "noncurrentfinancialassets": 37005000,
    "decreasethroughderecognitionnoncurrentfinancialassets": 2000000,
    "gainslossesonnoncurrentfinancialassetsatfairvaluethroughprofitorloss": 3585000,
    "gainslossesonnoncurrentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincomebeforetax": 237000,
    "increasedecreasethroughforeignexchangeandothermovementsnoncurrentfinancialassets": 37005000,
    "decreasethroughderecognitionshortterminvestmentandnoncurrentfinancialassets": 2000000,
    "gainslossesonshortterminvestmentandnoncurrentfinancialassetsatfairvaluethroughprofitorloss": 4065000,
    "gainslossesonshortterminvestmentandnoncurrentfinancialassetsmeasuredatfairvaluethroughothercomprehensiveincomebeforetax": 237000,
    "interestincomeforshorttermandnoncurrentfinancialassetsnotatfairvaluethroughprofitorloss": -280000,
    "increasedecreasethroughforeignexchangeandothermovementsshortterminvestmentnoncurrentfinancialassets": 52983000,
    "acquisitionsthroughbusinesscombinationsintangibleassetsotherthangoodwill": 59000,
    "increasedecreasethroughtransfersintangibleassetsotherthangoodwill": -139000,
    "propertyplantandequipment": 6270000,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 1102000,
    "disposalspropertyplantandequipment": 97000,
    "increasedecreasethroughtransferspropertyplantandequipment": 139000,
    "depreciationpropertyplantandequipment": 852000,
    "totalpropertyplantandequipmentadoptionofnewifrsstandards": 1097000,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 1982000,
    "decreaseindownpayment": 161000,
    "financialliabilitiesdownpayment": 74000,
    "financialliabilitiesimpactofifrsadoption": 1168000,
    "proceedsfromleaseliabilities": 1119000,
    "bankborrowingsundiscountedcashflows": 20585000,
    "bankborrowingsundiscountedcashflowsdownpayment": 74000,
    "numberofinstrumentsotherequityinstrumentsgranted": 1074726,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": 622000,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslation": 5000,
    "comprehensiveincome": -20132000,
    "allocationofpriorperiodincomeequity": -3049000,
    "increasedecreaseinnumberofsharesissuedfromexerciseandsubscriptionofequityinstruments": 511035,
    "increasedecreasethroughexerciseandsubscriptionofequityinstrumentsequity": 46000,
    "increasedecreasethroughsharebasedpaymenttransactions": 3826000,
    "increasedecreaseinnumberofsharesissuedfromnewsharesissued": 14375000,
    "issueofequity": 66558000,
    "numberofotherequityinstrumentsforfeitedinsharebasedpaymentarrangement": 39783,
    "numberofotherequityinstrumentsexercisedorvestedinsharebasedpaymentarrangement": 750,
    "numberofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement": 66940,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 309500,
    "weightedaverageexercisepriceofotherequityinstrumentsoutstandinginsharebasedpaymentarrangement2019": 11,
    "incomefromgovernmentfinancingforresearchexpenditures": 16840000,
    "revenue": 85814000,
    "sellinggeneralandadministrativeexpense": 25803000,
    "operatingexpense": 25803000,
    "profitlossfromoperatingactivities": -27052000,
    "financeincome": 11269000,
    "financecosts": 4976000,
    "financeincomecost": 6293000,
    "profitlossbeforetax": -20759000,
    "basicearningslosspershare": -0.31,
    "dilutedearningslosspershare": -0.31,
    "closingforeignexchangerate": 1.1195,
    "averageforeignexchangerate": 1.1234,
    "cashandcashequivalents": 202887000,
    "currentfinancialassets": 15978000,
    "othercurrenttaxcreditsreceivables": 333000,
    "currentprepaidexpenses": 5403000,
    "currentvalueaddedtaxreceivables": 1995000,
    "currenttradereceivables": 2816000,
    "currentadvancestosuppliers": 197000,
    "tradeandothercurrentreceivablesexcludingrebates": 18741000,
    "noncurrentresearchtaxcredit": 16737000,
    "tradeandothernoncurrentreceivablesexcludingrebates": 16737000,
    "tradeandotherreceivablesexcludingrebates": 28716000,
    "tradeandothercurrentpayablestotradesuppliers": 27936000,
    "payablesonsocialsecurityandtaxesotherthanincometax": 6999000,
    "othercurrentpayables": 1111000,
    "currenttradepayablesandothersexcludingpayablesrelatedtocapitalexpenditures": 36047000,
    "currentpayablesrelatedtocapitalexpenditures": 13458000,
    "tradeandothercurrentpayables": 49504000,
    "currentfinancialliabilities": 2130000,
    "noncurrentfinancialliabilities": 16593000,
    "definedbenefitobligationatpresentvalue": 3760000,
    "financialassets": 35477000,
    "financialassetsatfairvalue": 291347000,
    "financialliabilitiestradepayablesandothers": 68227000,
    "financialliabilitiestradepayablesandothersatfairvalue": 68227000,
    "incomefromresearchtaxcredit": 16737000,
    "revenuefromgovernmentgrants": 103000,
    "interestsandgainsonfinancialassets": 1620000,
    "unrealizedgainsonfinancialassets": 4063000,
    "netforeignexchangegain": 5568000,
    "otherfinancialincome": 18000,
    "netforeignexchangeloss": 4772000,
    "interestexpense": 204000,
    "otherfinancialexpenses": 1000,
    "accountingprofit": -20759000,
    "applicabletaxrate": 0.31,
    "taxexpenseincomeatapplicabletaxrate": -6435000,
    "taxeffectfromdifferencesintaxrates": 137000,
    "taxeffectofresearchtaxcredit": 5021000,
    "taxeffectofdefinedbenefitobligations": 20000,
    "taxeffectofsharebasedcompensation": 1186000,
    "taxeffectofrevenuefromcollaborationswithcustomers": 5251000,
    "taxeffectofnonrecognitionofdeferredtaxassetsrelatedtotaxlossesandtemporarydifferences": 5136000,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 2811000,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 12000,
    "keymanagementpersonnelcompensationsharebasedpayment": 2450000,
    "keymanagementpersonnelcompensation": 5273000,
    "cashadvancesandloansfromrelatedparties": 118627000,
    "amountsreceivablerelatedpartytransactions": 9140000,
    "cashadvancesandloansmadetorelatedparties": 73973000,
    "cashreceiptsfromrepaymentofadvancesandloansmadetorelatedparties": 44654000,
    "netamountsreceivablepayablerelatedpartytransactions": -27156000,
    "weightedaverageshares": 66908389,
    "othercomprehensiveincome": 627000,
    "othernoncurrentnonfinancialassets": 89000,
    "noncurrentreceivables": 16737000,
    "netdeferredtaxassets": 1286000,
    "noncurrentassets": 163756000,
    "tradeandothercurrentreceivables": 18740000,
    "currentassets": 237605000,
    "assets": 401361000,
    "sharepremium": 369617000,
    "noncurrentrecognisedliabilitiesdefinedbenefitplan": 3760000,
    "noncurrentprovisions": 142000,
    "netdeferredtaxliabilities": 1286000,
    "noncurrentliabilities": 62123000,
    "currentprovisions": 114000,
    "currentliabilities": 121822000,
    "equityandliabilities": 401361000,
    "actuarialassumptionofdiscountrates": 0.0105,
    "actuarialassumptionofexpectedratesofsalaryincreases": 0.03,
    "actuarialassumptionsannualmobilityrate": 0.019,
    "actuarialassumptionsrateofcontributions": 0.4707,
    "actuarialassumptionsrateofwagescosts": 0.2254,
    "actuarialassumptionofretirementage2019": "P62Y",
    "actuarialassumptionofannualturnoverratebyage1624years": 0.05,
    "actuarialassumptionofannualturnoverratebyage2529years": 0.035,
    "actuarialassumptionofannualturnoverratebyage3034years": 0.025,
    "actuarialassumptionofannualturnoverratebyage3439years": 0.02,
    "actuarialassumptionofannualturnoverratebyage4044years": 0.015,
    "actuarialassumptionofannualturnoverratebyage4549years": 0.01,
    "subcontractingcosts": 41193000,
    "employeebenefitsexpense": 26464000,
    "nonscientificadvisoryandconsulting": 8655000,
    "leasingandmaintenance": 1872000,
    "travelexpense": 1754000,
    "salesandmarketingexpense": 629000,
    "scientificadvisoryandconsulting": 223000,
    "otherpurchasesandexternalexpenses": 814000,
    "depreciationandamortisationexpense": 16530000,
    "otheroperatingincomeexpense": -1719000,
    "auditorsremunerationforauditservices": 1190000,
    "auditorsremunerationforotherservices": 2000,
    "auditorsremuneration": 1192000,
    "adjustmentsfordepreciationandamortisationexpense": 16529000,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 685000,
    "adjustmentsforprovisions": -484000,
    "adjustmentsforsharebasedpayments": 3826000,
    "adjustmentsforfairvaluegainslosses": -4065000,
    "adjustmentsforunrealisedforeignexchangelossesgains": -280000,
    "adjustmentsfordecreaseincreaseinaccruedinterestsonfinancialassets": -237000,
    "gainslossesonassetsandotherfinancialassets": 1290000,
    "interestpaid": 204000,
    "otheradjustmentstoreconcileprofitloss": 550000,
    "cashflowsfromusedinoperationsbeforechangesinworkingcapital": -5321000,
    "increasedecreaseinworkingcapital": -40245000,
    "cashflowsfromusedinoperatingactivities": 34924000,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 1271000,
    "proceedspaymentsfromsalesofotherlongtermassetsinvestingactivities": -10000,
    "proceedsfromdisposalofnoncurrentfinancialinstruments": 2000000,
    "interestreceivedclassifiedasinvestingactivities": 1290000,
    "cashflowsfromusedininvestingactivities": -62121000,
    "proceedsfromexerciseorsubscriptionofequityinstruments": 44000,
    "increasedecreaseinworkingcapitalclassifiedasfinancingactivities": 66006000,
    "interestpaidclassifiedasfinancingactivities": 204000,
    "cashflowsfromusedinfinancingactivities": 77765000,
    "effectofexchangeratechangesoncashandcashequivalents": 5000,
    "increasedecreaseincashandcashequivalents": 50572000,
    "tradeandotherreceivables": 28716000,
    "tradeandotherpayables": 36047000,
    "workingcapital": -117747000
  }
]